Lowey Dannenberg Notifies UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDQ: URGN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDQ: URGN) for violations of the federal securities laws on behalf of investors who purchased or acquired UroGen securities between July 27, 2023 and May 15, 2025, inclusive (the “Class Period”).

Source: https://www.globenewswire.com/news-release/2025/07/11/3114117/0/en/Lowey-Dannenberg-Notifies-UroGen-Pharma-Ltd-UroGen-or-the-Company-NASDQ-URGN-Investors-of-Securities-Class-Action-Lawsuit-and-Encourages-Investors-with-more-than-50-000-in-Losses-t.html